toxoplasmosis: a rare cause of iris in hiv infected patients. case series

1
ORAL PRESENTATION Open Access Toxoplasmosis: a rare cause of IRIS in HIV infected patients. Case series Ruxandra Moroti 1,2* , Daniela Munteanu 1 , Mihaela Rădulescu 1,2 , Adriana Hristea 1,2 , Iulia Niculescu 1,2 , Raluca Mihăilescu 1 , Roxana Petre 1,3 , Raluca Hrişcă 1,3 , Raluca Jipa 1,3 , Ana Maria Petrescu 1 , Maria Nica 4 , Mihai Lazăr 1,2 , Anca-Ruxandra Negru 1 , Irina Lăpădat 1 , Angelica Teniță 1 , Victoria Aramă 1,2 From The 9th Edition of the Scientific Days of the National Institute for Infectious Diseases Prof Dr Matei Bals Bucharest, Romania. 23-25 October 2013 Background Cerebral toxoplasmosis is one of the main 3 intracerebral opportunistic infections in HIV positive patients, along with cryptococcosis and tuberculosis. In comparison to these last 2 entities, toxoplasmosis does not provoke or very rarely provokes reconstitution syndromes. Methods We analyzed a case series of 3 patients with cerebral toxo- plasmosis admitted in the Adults III Department of the National Institute for Infectious Diseases Prof. Dr. Matei Balşin 2012-2013. Results Three patients, one male and 2 women, aged 55 years old, respectively 41 and 42 year-old, all 3 diagnosed concomi- tantly with HIV infection (as very late presenters) and cere- bral toxoplasmosis, with a CD4 count of 6, 6 and 7/cmm respectively, viral loads (VL) of 254,000, 57,000 and 156,000 copies/mL respectively, and CSF viral load below the plasmatic VL in all 3 cases. We recorded minimal abnormalities of CSF analysis regarding the number of cells and biochemical exams; all had positive PCR for Toxo- plasma gondii in the CSF and positive serology (IgG). All 3 had intracerebral lesions (abscesses) and all were biopsied at the neurosurgery department for diagnostic purpose before knowing their HIV-positive status. They received high doses of oral trimethoprim/sulfamethoxazole (T/S) for toxoplasmosis and antiretroviral therapy in the first 2 weeks after the diagnosis. They repeated cerebral imagery (MRI) after 3 weeks of T/S and had no regression of the size of lesions (although with the decreasing of perilesional edema) and new lesions, in two cases without having corre- sponding symptoms; in all 3 cases the CD4 count increased in the first month more than 100%. The search for another cause for the augmentation of their brain lesions was nega- tive. Maintaining the same medication, the next imagery exams showed improvement in 2 out of 3 cases, in which the outcome was favorable with almost complete neurolo- gical recovery. In the remaining case the evolution was unfavorable (death). Conclusions In our 3 cases we presumed a paradoxical toxoplasmosis IRIS, with little or no clinical deterioration strictly linked with imagery exams depreciation in 2 out of 3 cases but with a fatal evolution in one case. Even rarely reported, the toxoplasmosis IRIS could be taken into account in some situations. Authorsdetails 1 National Institute for Infectious Diseases Prof. Dr. Matei Balş, Bucharest, Romania. 2 Carol Davila University of Medicine and Pharmacy, Bucharest, Romania. 3 Central Universitary Emergency Military Hospital Dr Carol Davila, Bucharest, Romania. 4 Clinical Hospital of Infectious and Tropical Diseases Dr. Victor Babeş, Bucharest, Romania. Published: 16 December 2013 doi:10.1186/1471-2334-13-S1-O7 Cite this article as: Moroti et al.: Toxoplasmosis: a rare cause of IRIS in HIV infected patients. Case series. BMC Infectious Diseases 2013 13(Suppl 1):O7. * Correspondence: [email protected] 1 National Institute for Infectious Diseases Prof. Dr. Matei Balş, Bucharest, Romania Full list of author information is available at the end of the article Moroti et al. BMC Infectious Diseases 2013, 13(Suppl 1):O7 http://www.biomedcentral.com/1471-2334/13/S1/O7 © 2013 Moroti et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Upload: victoria

Post on 23-Dec-2016

213 views

Category:

Documents


0 download

TRANSCRIPT

ORAL PRESENTATION Open Access

Toxoplasmosis: a rare cause of IRIS in HIVinfected patients. Case seriesRuxandra Moroti1,2*, Daniela Munteanu1, Mihaela Rădulescu1,2, Adriana Hristea1,2, Iulia Niculescu1,2,Raluca Mihăilescu1, Roxana Petre1,3, Raluca Hrişcă1,3, Raluca Jipa1,3, Ana Maria Petrescu1, Maria Nica4, Mihai Lazăr1,2,Anca-Ruxandra Negru1, Irina Lăpădat1, Angelica Teniță1, Victoria Aramă1,2

From The 9th Edition of the Scientific Days of the National Institute for Infectious Diseases Prof Dr Matei BalsBucharest, Romania. 23-25 October 2013

BackgroundCerebral toxoplasmosis is one of the main 3 intracerebralopportunistic infections in HIV positive patients, alongwith cryptococcosis and tuberculosis. In comparison tothese last 2 entities, toxoplasmosis does not provoke orvery rarely provokes reconstitution syndromes.

MethodsWe analyzed a case series of 3 patients with cerebral toxo-plasmosis admitted in the Adults III Department of theNational Institute for Infectious Diseases “Prof. Dr. MateiBalş” in 2012-2013.

ResultsThree patients, one male and 2 women, aged 55 years old,respectively 41 and 42 year-old, all 3 diagnosed concomi-tantly with HIV infection (as very late presenters) and cere-bral toxoplasmosis, with a CD4 count of 6, 6 and 7/cmmrespectively, viral loads (VL) of 254,000, 57,000 and156,000 copies/mL respectively, and CSF viral load belowthe plasmatic VL in all 3 cases. We recorded minimalabnormalities of CSF analysis regarding the number ofcells and biochemical exams; all had positive PCR for Toxo-plasma gondii in the CSF and positive serology (IgG). All3 had intracerebral lesions (abscesses) and all were biopsiedat the neurosurgery department for diagnostic purposebefore knowing their HIV-positive status. They receivedhigh doses of oral trimethoprim/sulfamethoxazole (T/S)for toxoplasmosis and antiretroviral therapy in the first2 weeks after the diagnosis. They repeated cerebral imagery(MRI) after 3 weeks of T/S and had no regression of the

size of lesions (although with the decreasing of perilesionaledema) and new lesions, in two cases without having corre-sponding symptoms; in all 3 cases the CD4 count increasedin the first month more than 100%. The search for anothercause for the augmentation of their brain lesions was nega-tive. Maintaining the same medication, the next imageryexams showed improvement in 2 out of 3 cases, in whichthe outcome was favorable with almost complete neurolo-gical recovery. In the remaining case the evolution wasunfavorable (death).

ConclusionsIn our 3 cases we presumed a paradoxical toxoplasmosisIRIS, with little or no clinical deterioration strictly linkedwith imagery exams depreciation in 2 out of 3 cases butwith a fatal evolution in one case. Even rarely reported,the toxoplasmosis IRIS could be taken into account insome situations.

Authors’ details1National Institute for Infectious Diseases “Prof. Dr. Matei Balş”, Bucharest,Romania. 2Carol Davila University of Medicine and Pharmacy, Bucharest,Romania. 3Central Universitary Emergency Military Hospital Dr Carol Davila,Bucharest, Romania. 4Clinical Hospital of Infectious and Tropical Diseases “Dr.Victor Babeş”, Bucharest, Romania.

Published: 16 December 2013

doi:10.1186/1471-2334-13-S1-O7Cite this article as: Moroti et al.: Toxoplasmosis: a rare cause of IRIS inHIV infected patients. Case series. BMC Infectious Diseases 201313(Suppl 1):O7.

* Correspondence: [email protected] Institute for Infectious Diseases “Prof. Dr. Matei Balş”, Bucharest,RomaniaFull list of author information is available at the end of the article

Moroti et al. BMC Infectious Diseases 2013, 13(Suppl 1):O7http://www.biomedcentral.com/1471-2334/13/S1/O7

© 2013 Moroti et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative CommonsAttribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction inany medium, provided the original work is properly cited.